Page 2 - Advm News Today

Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […]

Truist Financial restated their buy rating on shares of Adverum Biotechnologies (NASDAQ:ADVM – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. StockNews.com initiated coverage on shares of Adverum Biotechnologies […]

The best cat food ensures your feline friend remains happy and healthy for as long as possible. Here are the best options for 2023.

StockNews.com initiated coverage on shares of Adverum Biotechnologies (NASDAQ:ADVM – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Chardan Capital raised Adverum Biotechnologies from a neutral rating to a buy rating and lifted their price objective for the stock from $2.00 to […]

CM Management LLC raised its holdings in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 275.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 375,000 shares of the biotechnology company’s stock after acquiring an additional 275,000 shares during the period. CM Management LLC’s holdings in Adverum […]

BML Capital Management LLC bought a new stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 7,067,179 shares of the biotechnology company’s stock, valued at approximately $4,095,000. Adverum Biotechnologies comprises about 3.9% of […]

StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report released on Saturday morning. Separately, LADENBURG THALM/SH SH started coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They issued a buy rating and a $2.00 target price on […]

StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report report published on Saturday. Separately, LADENBURG THALM/SH SH began coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 target price for […]

StockNews.com lowered shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a hold rating to a sell rating in a research report released on Friday morning. Separately, LADENBURG THALM/SH SH assumed coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 price objective on […]

Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.74 and traded as high as $0.91. Adverum Biotechnologies shares last traded at $0.91, with a volume of 295,073 shares trading hands. Wall Street Analyst […]